Apixaban

APPRAISE-1: Safety of the Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial

      -Trial Overview by Dr. John H. Alexander (ESC 2008)

 

APPRAISE-2: Apixaban with Antiplatelet Therapy After Acute Coronary Syndrome

      -Trial Results by Dr. John H. Alexander

 

ARISTOTLE: Apixaban versus Warfarin in Patients with Atrial Fibrillation

      -Trial Results by Dr. Christopher Granger and Dr. Lars Wallentin (ESC 2011)

      -Efficacy and Safety by Dr. Christopher Granger and Dr. Lars Wallentin (ESC 2011)

 

ARISTOTLE Sub-analysis in Japanese patients: Apixaban versus Warfarin in Patients with Atrial Fibrillation

      -Study Overview by Dr. Shinya Goto (ACC 2012)

 

ARISTOTLE CHADS Subgroup Study: Efficacy and Safety of Apixaban Compared with Warfarin According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation

      -Study Overview by Dr. Renato Lopes (ACC 2012)

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster